TABLE 3.
Variable | Hazard Ratio | 95% CI | P |
---|---|---|---|
Netherlands:United States | 1.15 | 0.74–1.78 | 0.55 |
Japan:United States | 1.45 | 0.98–2.16 | 0.07 |
Male <13 y:female <13 y | 1.72 | 1.25–2.38 | <0.001 |
Female 13–40 y:male 13–40 y | 2.27 | 1.30–3.96 | <0.01 |
QTc 500–530 ms:QTc <500 ms | 2.04 | 1.41–2.96 | <0.001 |
QTc >530 ms:QTc <500 ms | 3.25 | 2.25–4.69 | <0.001 |
QTc missing*:QTC <500 ms | 2.26 | 1.57–3.25 | <0.001 |
Transmembrane:C-terminus | 2.06 | 1.36–3.12 | <0.001 |
Missense yes:no | 1.33 | 0.86–2.05 | 0.20 |
Intron:C-terminus | 2.45 | 0.98–6.11 | 0.06 |
Time-dependent β-blocker use | 0.26 | 0.14–0.49 | <0.001 |
The Cox analysis involved 592 subjects with 445 transmembrane, 126 C-terminus, 2 N-terminus, and 19 intron mutations; 8 subjects were not included in this Cox analysis because of missing data about the date of their first cardiac event.
QTc missing category involves 47 subjects who died suddenly at a young age without a prior ECG.